NEAT ID MASH-1 Adult Registry Study
Study profileDescription
The NEAT ID MASH-1 Adult Registry Study collects data retrospectively from routine clinical care records on adults living with HIV, and adults taking HIV pre-exposure prophylaxis (PrEP), who are diagnosed with mpox at clinical sites in the NEAT ID network in UK, France and Spain, plus a recruiting network site in Poland, gathering participants from eight Central / Eastern European countries (Czech Republic, Poland, Romania, Serbia, Hungary, Croatia, Bosnia and Bulgaria).
Sponsor:
Countries involved: France, Czech Republic, Poland, Romania, Serbia, Hungary, Croatia, Bosnia, Bulgaria, Spain, UK
Sample size: 2,000 adults
Metadata collected
Click to view
| Data collected? | |
| Demographics | |
| Date of birth | ✅ * |
| Age at contact | ✅ |
| Sex | ✅ |
| Gender | ✅ |
| Ethnic group | ✅ |
| Locality (of registration/ health care setting) | ✅ |
| Locality of residence | |
| *year of birth | |
| Health status and exposures | |
| Height | |
| Weight | |
| Date of anthropometrics | |
| HIV status, timing of HIV diagnosis | ✅ ~ |
| HIV treatment | ✅ |
| HIV pre-exposure prophylaxis | ✅ ~ |
| HIV-related lab tests (HIV RNA, CD4) | ✅ |
| Other co-morbid conditions / co-infections | ✅ |
| Medications for other chronic conditions | ✅ |
| Current smoker | |
| Risk factors for mpox acquisition | ✅ |
| ~study restricted to those living with HIV or receiving PrEP | |
| Mpox/other infections presentation, symptoms, medications, hospitalisation | |
| Date of symptom onset | ✅ |
| Signs and symptoms | ✅ |
| Lesion assessment | ✅ |
| Lesion resolution | ✅ |
| Outpatient facility presentation dates | |
| Hospitalisation dates | ✅ |
| ICU admission | |
| Procedures and dates | |
| Complications | ✅ |
| Medications (type, dates / duration) | ✅ |
| Medical management | |
| Imaging findings* | |
| Severe disease indicators | ✅ |
| *exposed infants and pregnancy ultrasounds | |
| Mpox/ other infections outcomes, death | |
| Outcome at discharge from care | ✅ |
| Sequelae | |
| Date of / age at death | ✅ |
| Cause of death | ✅ * |
| Place of death (i.e., setting) | |
| *if mpox-related | |
| Vaccines | |
| Mpox / orthopoxvirus vaccine doses and dates | ✅ |
| Vaccine administration route | |
| Vaccine history | |
| Pregnancy & birth | |
| Pregnancy dates, length of gestation | |
| Number of fetuses | |
| Maternal age at delivery | |
| Pregnancy complications | |
| Pregnancy outcome | |
| Medications in pregnancy | |
| Vaccines in pregnancy | |
| Parity / gravidity | |
| Smoking | |
| Mpox testing in pregnancy | |
| Mode of delivery | |
| Sex of baby | |
| Infant anthropometrics at birth | |
| Congenital anomalies | |
| Mpox/ other infections diagnostics | |
| Sample type | |
| Sample date | |
| Type of PCR test | |
| PCR test date | ✅ |
| PCR result pos / neg | ✅ |
| PCR Ct value | |
| Type of serology test | |
| Serology test date | |
| Serology result | |
| Other lab tests | |
| Mpox/ other infections sample collection / storage | |
| Sample type collected | |
| Sample collection date | |
| Sample collection time | |
| Sample processing | |
| Sample quality | |
| Consent to use research sample | |
| Consent to share research sample | |